LEADER 05585nam 2200685 450 001 9910819384303321 005 20230807204733.0 010 $a1-61705-106-3 035 $a(CKB)2670000000590633 035 $a(EBL)1910141 035 $a(SSID)ssj0001402746 035 $a(PQKBManifestationID)12516878 035 $a(PQKBTitleCode)TC0001402746 035 $a(PQKBWorkID)11365380 035 $a(PQKB)10932319 035 $a(Au-PeEL)EBL1910141 035 $a(CaPaEBR)ebr11012595 035 $a(CaONFJC)MIL687731 035 $a(OCoLC)899158351 035 $a(MiAaPQ)EBC1910141 035 $a(EXLCZ)992670000000590633 100 $a20150209h20152015 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aProstate cancer $ea multidisciplinary approach to diagnosis and management /$fedited by Adam P. Dicker [and three others] ; contributors, Neeraj Agarwal [and one hundred four others] 210 1$aNew York, New York :$cDemos Medical,$d2015. 210 4$dİ2015 215 $a1 online resource (438 p.) 225 1 $aCurrent Multidisciplinary Oncology 300 $aDescription based upon print version of record. 311 $a1-936287-59-5 311 $a1-322-56449-3 320 $aIncludes bibliographical references and index at the end of each chapters. 327 $aCover; Title; Copyright; Contents; Contributors; Series Foreword; Preface; Acknowledgments; Share Prostate Cancer: A Multidisciplinary Approach to Diagnosis and Management; Part I: Epidemiology, Screening, and Diagnosis; Chapter 1: Introduction: The Multidisciplinary Approach to Prostate Cancer; Prostate Cancer in the 20th Century; Prostate Cancer in the 21st Century; Prostate Cancer Patient Descision Making; The Multidisciplinary Approach to Prostate Cancer; Experience with the Multidisciplinary Approach to Prostate Cancer; Conclusions; References 327 $aChapter 2.1: Epidemiology of Prostate CancerIntroduction; Global Burden of Prostate Cancer; Established Risk Factors for Total Prostate Cancer Incidence; Overview of Potential Risk Factors for Lethal Prostate Cancer; Summary; References; Chapter 2.2: Diet and Prostate Cancer; Introduction; The Variable Course of Prostate Cancer; Nutritional Components of the Diet; Obesity as a Marker of Energy Imbalance; Issues for Future Research; References; Chapter 2.3: Epidemiology: Obesity as a Risk Factor; Introduction; Obesity and PC Incidence; Obesity and PC Treatment 327 $aObesity and PC-Specific MortalityConclusions; References; Chapter 3.1.1: Screening and Diagnosis: The Pros of PSA Screening; References; Chapter 3.1.2: The Argument Against Prostate Cancer Screening; A Brief History; Does PSA Screening Find Localized Prostate Cancer?; Does Treatment of Localized Disease Save Lives?; Does Screening Prevent Death From Prostate Cancer?; A Comparison of Populations; The Prospective Randomized Trials; Applying Clinical Studies to the Real World; Summary; References; Chapter 3.1.3: How Do We Improve PSA Accuracy?; Introduction; PSA Cutoff Threshold 327 $aPercent of Free PSA (%FPSA)PSA Velocity; PSA Density; Individualized Predicting Tools for Prostate Cancer; Guidelines by American Urological Association; Conclusions; References; Chapter 3.2: Screening and Diagnosis: An Update on the ISUP-Modified Gleason Score and Its Controversies; Gleason Scoring System-A Brief History; The Need to Update the System; 2005 ISUP Consensus Conference and Subsequent Modifications; Issues Relating Specifically to Needle Biopsies and Radical Prostatectomy Specimens; Implications and Results of the ISUP-Modified Gleason Grading System 327 $aLingering Problems of the Gleason Grading SystemIs it Time for a Modified Grouping of Gleason Scores for Prognostic Studies?; Conclusions; References; Chapter 3.3: Evaluation of Distant Disease: The Utility of Nuclear Imaging; Introduction; 18F-FDG; 18F-Sodium Fluoride; Choline: 18F-Choline and 11C-Choline; Acetate: 11C-Acetate; Amino Acids: 11C-Methionine and 18F-FACBC; 18F-FDHT; Prostate-Specific Membrane Antigen-Targeted Pet Agents; HER2; Conclusion; References; Chapter 4: Current Approaches to Prostate Cancer Staging and Risk Stratification: In the Midst of a Paradigm Shift; Introduction 327 $aClinical Staging for Initial Diagnosis and Treatment 330 $aWith an emphasis on multidisciplinary collaboration and decision-making, this practical resource reflects the extraordinary advances in the treatment of prostate cancer during the past five years. Approximately thirty international, leading-edge investigators describe the most current evidence-based approaches to prostate cancer treatment. The book provides a comprehensive view of the entire spectrum of prostate cancer management from initial screening through novel and experimental treatments that have the potential for a major impact on practice.The book first reviews fundamental issues incl 410 0$aCurrent multidisciplinary oncology. 606 $aProstate$xCancer$xDiagnosis 606 $aProstate$xCancer$xSurgery 606 $aProstate$xCancer$xTreatment 615 0$aProstate$xCancer$xDiagnosis. 615 0$aProstate$xCancer$xSurgery. 615 0$aProstate$xCancer$xTreatment. 676 $a616.99/463 702 $aDicker$b Adam P. 702 $aAgarwal$b N$g(Neeraj), 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910819384303321 996 $aProstate Cancer$91754837 997 $aUNINA